For research use only. Not for therapeutic Use.
p38 MAP Kinase Inhibitor VI (compound c32) is a p38 MAPK inhibitor with an inhibition rate of 24%[1].
Catalog Number | I040459 |
CAS Number | 421578-46-3 |
Synonyms | 2-(5,6-dimethylthieno[2,3-d]pyrimidin-4-yl)sulfanyl-1-(4-fluorophenyl)ethanone |
Molecular Formula | C16H13FN2OS2 |
Purity | ≥95% |
InChI | InChI=1S/C16H13FN2OS2/c1-9-10(2)22-16-14(9)15(18-8-19-16)21-7-13(20)11-3-5-12(17)6-4-11/h3-6,8H,7H2,1-2H3 |
InChIKey | UGHHFQVLSOSMQA-UHFFFAOYSA-N |
SMILES | CC1=C(SC2=C1C(=NC=N2)SCC(=O)C3=CC=C(C=C3)F)C |
Reference | [1]. Cheeseright TJ, et al. Novel lead structures for p38 MAP kinase via FieldScreen virtual screening. J Med Chem. 2009 Jul 23;52(14):4200-9. |